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Abstract 
Background: To describe the clinical presentation and 
complications of von Willebrand disease(vWD). 
Methods: In this descriptive study, out of 426 
patients,visiting the hemophilia welfare society Lahore, 57 
cases of vWD, diagnosed on the basis of clinical features, 
prolonged bleeding time (BT), prolonged APTT and 
decreased vWF antigen were enrolled. 
Results: Most of the patients (49.1%) were diagnosed at 
less than one year of age while 35% patients were 
diagnosed between 1-5 years of age and 15.8% were 
diagnosed at the age of more than 5 years. Family history 
of bleeding disorder was found in 60%. Common clinical 
presentation of disease was epistaxis (77.2%), easy 
bruising (64.9%) and mennorhagia (21.1%). Disease 
complications were seen in 35% patients. Hepatitis C was 
the commonest complication (31.6%). Arthropathy was 
seen in 22.8%. CNS complications and Hepatitis B were 
seen in 1.8% each.  
Conclusion: In inherited bleeding disorders patients , 
with soft tissue bleeds, vWD is the commonest  
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Introduction 
     Von Willebrand disease (vWD) is the most common 
inherited bleeding disorder,which occurs due to 
quantitative or qualitative defects of von Willebrand 
factor (vWF) 1,2. VWF is a large multimeric protein 
which causes platelet adhesion to blood vessel. It also 
acts as a carrier protein for clotting factor VIII. VWD is 
classified into three major types. Type I occurs due to 
partial deficiency of vWF.  Type II includes functional 
defects in vWF. Patients with type III have complete 
deficiency of vWF and a secondary severe deficiency 
of F VIII. Type II is further divided into four subtypes 
2A, 2B, 2N and 2M. Type 2A and 2B occur due to 
absence of largest vWF multimers. Type 2M is 
associated with specific defects in platelet and type 2N 
with F VIII binding domains3, 4. Patient usually 
presents with mucosal bleeding. Epistaxis, gum 
bleeding, bleeding after trauma or surgery and 
mennorhagia are common clinical features5,6. Bleeding 
tendency is less severe in vWD so regular treatment is 
not required. Replacement of deficient protein before 
surgery, invasive procedure or at the time of bleeding 
is required..  7-11  
 
Patients and Methods 
     Patients reporting to Pakistan Hemophilia Welfare 
Association Lahore were included in this study. Out of 
426 patients, 57 patients were diagnosed as vWD. 
Informed consent was taken from all patients. 
Proforma included personal and family history, 
clinical presentation of patients like epistaxis, easy 
bruising, menorrhagia, and mucous membrane 
bleeding during dental work. Family history of an 
autosomal dominant or recessive inherited bleeding 
disorder or easy bruising with indurations, which 
could also indicate the presence of vWD. The history 
of first bleed and bleeding episodes per month were 
also recorded. Complications of disease like 
arthropathy, joint deformities, CNS complications, 
hepatitis B, C and HIV infection were also recorded. 
Coagulation tests were performed on venous blood 
samples collected in vaccutainers containing 3.2% 
sodium citrate (BD). APTT, platelet count, and 
bleeding time, vWF levels, factor VIII levels and VWD: 
RCo assay were performed to establish  the diagnosis.  
  
Results 
     A total 57 patients of vWD were enrolled in this 
study. Most of the patients 28 (49.1%) were diagnosed 
at less than one year of age while 20 (35%) patients 
were diagnosed between 1-5 years of age. Only 9 
(15.8%) patients were diagnosed at more than 5 years 
of age (Table-1). Majority(60%) patients had positive 
family history of bleeding disorder. Out of these 
positive family history patients , 28 patients had family 
history of VWD, 5 had history of haemophilia A and 
one had unknown bleeding disorder. Relation with 
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these patients is shown in Table 2. First cousin 
marriages were seen in 39 (68.4%), while marriages 
within family but not first cousins in 11(19.2%) and out 
of family marriages in 7(12%) patients. (Table 1). 
 
Table 1:Demographic data of patients 
                     Age Profile 
Age Frequency Percentage (%) 
Up to 1 year 28 /57 49.1 
1-5 years  20/57 35.1 
 5-23 years 9 /57 15.8 
Consanguinity 
First Cousin               
            
39 /57 68.4 
Family marriages 11/57 19.2 
Out of family  
  marriages 
7/57 12 
 
Table 2:Family History of Bleeding Diathesis 
Positive 34 /57 59.6% 
Negative 23  /57 40.3% 
Relation with patient 
Sister 11 32.3% 
Brother 9 26.4% 
Maternal 
uncle 
6 17.6% 
Maternal 
cousin 
4 11.7% 
Cousin, 
nephew 
2 5.8% 
Paternal 
uncle 
1 2.9% 
Aunt 1 2.9% 
Sex of relative 
Male 21 61.8% 
Female 13 38.2% 
 
 
     In majority of the cases (66.7%) the frequency of 
bleeding episodes was less than one per month. In 17 
patients bleeding episodes were 1-3 per month and 2 
patients presented with more than 3 episodes / 
month. Most of the patients 25(43.9%) presented with 
first bleed at circumcision and 11(19.3%) each with 
simple injuries and easy bruisibility while 10(17.5%) 
patients presented with others like menorrhagia, gum 
bleed and epistaxis. (Table: 3).  
     Common clinical presentations seen during the 
whole course of disease was epistaxis in 44(77.2%) 
patients. Easy bruising was present in 37(65%) and 
menorrhagia in 12(21.1%). Disease complications were 
noted in 20 out of 57 patients. arthopathy in 15, joint 
deformity in four and CNS complications in one 
patient only.Hepatitis C was the most common 
infection which was present in these patients 18(31.6%) 
while hepatitis B was only seen in one. 
Table 3: Bleeding History of Patients 
Bleeding Episodes/Month Number(%) 
<1 38(66.7%) 
1-3 17(29.8) 
First Presentation of Disease 
Circumcision 25(43.9) 
Simple Injury 11(19.3) 
Easy Bruisibility 11(19.3) 
Others   10(17.5) 
 
Discussion 
      vWD is a hereditary bleeding disorder. It occurs 
due to absence or reduction in the amount of vWF or 
loss of its function. vWF is synthesized by 
megakaryocytes and endothelial cells. It is a 
glycoprotein that causes platelet adhesion to sub-
endothelium and platelet aggregation at sites of 
vascular injury to form platelet plug. It also acts as a 
carrier of clotting factor VIII in the circulation thus 
plays important role in primary haemostasis 12, 13. 
     Manifestations of disease are different ranging from 
minor to severe life threatening bleeding. 
Mucocutaneous bleed are the commonest 
presentation, while in hemophilia joint bleed is the 
commonest. A study conducted in India to see the 
prevalence and spectrum of vWD showed comparable 
results14. Shahbaz N et al reported in their study that 
mucocutaneous bleeding is the primary presentation 
of patients15. Another study in Eastern India showed 
the most common presentation of vWD is muco-
cutaneous bleeding. 14-16 
     Important aspect of disease we have noted in this 
study is consanguinity and family marriages among 
parents. It was also reported by Shahbazi et al in Iran 
that most of the patients were off springs of 
consanguineous marriages 17. A study conducted in 
Northern Pakistan showed consanguinity in 40.6% of 
parents.15 
      Family history of bleeding is present in 60% 
patients.  Family history of bleeding reported in a 
study by Metjian D.A et al was 58% 18. A study 
conducted in Karachi reported frequency of vWD 
among patients with positive family history of 
bleeding as 21.3% 19. In western India positive family 
history was noted in 15 families by Trasi S 14. 
      Disease complications were seen in 35% of patients. 
Most common complication was hepatitis C infection 
(31%). Arthopathy and joint deformity was present in 
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26% and 7% respectively. Manifestation of CNS 
complication was 1.7%. Metjian D.A et al also reported 
that joint bleed is present upto 45% and muscular 
bleed upto 28% in vWD.18 The high degree of Hepatitis 
C positivity shows that the screening profile of the 
transfused plasma is not upto the quality control 
standards which results into the transfer of  hepatitis B 
and C to the von Willebrand disease patients.  
 
Conclusion 
1. Many cases of vWD remain undiagnosed due  to 
varied clinical presentations and confounding 
impediments in lab diagnosis. 
2.Comprehensive evaluation of patients, followed by 
meticulous laboratory testing is necessary to diagnose 
vWD.  
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